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Abstract
Background: Effective antiretroviral therapy has greatly reduced HIV-related morbidity and mortality, dramatically changing
the demographics of the population of people living with HIV. The majority of people living with HIV in France are well cared
for insofar as their HIV infection is concerned but remain at risk for age-associated comorbidities. Their long-term, potentially
complex, and growing care needs make the routine, longitudinal assessment of health-related quality of life and other patient-reported
outcomes of relevance in the current treatment era.
Objective: We aim to describe the development of a Web-based electronic patient-reported outcomes system for people living
with HIV linked to the ANRS CO3 Aquitaine cohort’s data capture and visualization system (ARPEGE) and designed to facilitate
the electronic collection of patient-reported data and ultimately promote better patient-physician communication and quality of
care (both patient satisfaction and health outcomes).
Methods: Participants who meet the eligibility criteria will be invited to engage with the Web-based electronic patient-reported
outcomes system and provided with the information necessary to create a personal patient account. They will then be able to
access the electronic patient-reported outcomes system and complete a set of standardized validated questionnaires covering
health-related quality of life (World Health Organization's Quality of Life Instrument in HIV infection, named WHOQOL-HIV
BREF) and other patient-reported outcomes. The information provided via questionnaires will ultimately be presented in a
summary format for clinicians, together with the patient’s HIV care history.
Results: The prototype of the Web-based electronic patient-reported outcome system will be finalized and the first 2 formative
research phases of the study (prototyping and usability testing) will be conducted from December 2017 to May 2018. We describe
the sequential processes planned to ensure that the proposed electronic patient-reported outcome system is ready for formal pilot
testing, referred to herein as phases 1a and 1b. We also describe the planned pilot-testing designed to evaluate the acceptability
and use of the system from the patient’s perspective (phase 2).
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Conclusions: As the underlying information technology solution, ARPEGE, has being developed in-house, should the feasibility
study presented here yield promising results, the panel of services provided via the proposed portal could ultimately be expanded
and used to experiment with health-promoting interventions in aging people living with HIV in hospital-based care or adapted
for use in other patient populations.
Trial Registration: ClinicalTrials.gov NCT03296202; https://clinicaltrials.gov/ct2/show/NCT03296202 (Archived by WebCite
at http://www.webcitation.org/6zgOBArps)
Registered Report Identifier: RR1-10.2196/9439
(JMIR Res Protoc 2018;7(6):e147)  doi: 10.2196/resprot.9439
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Introduction
Background
The advent of effective antiretroviral therapy (ART) in 1996 in
resource-rich settings led to a sharp and rapid decline in
AIDS-related deaths [1]. In the following years and now
decades, improved treatment options have normalized the
survival of people living with HIV (PLWH) [2]. For PLWH to
benefit fully from ART, they must be engaged in the continuum
or cascade of HIV care. In other words, they must be diagnosed
early, linked and retained in care, and receive and adhere to
effective therapy [3]. The Joint United Nations Programme on
HIV and AIDS’ 90-90-90 targets aimed at ending HIV as a
public health threat by 2030 are premised on this continuum of
care [4]. They call for diagnosing at least 90% of people living
with HIV, getting at least 90% of those who are diagnosed on
ART, and achieving viral suppression in at least 90% of those
who are treated. In settings where the 90-90-90 targets have
already been achieved, Lazarus and colleagues have argued that
the ultimate goal of HIV care should be to improve
health-related quality of life (HRQoL) and have thus proposed
a fourth 90%: “achieving good health-related quality of life
among 90% of those who are successfully treated for HIV” [5].
This fourth 90% reflects the current needs of the population of
PLWH in much of Western Europe, including France, where
HIV has become a chronic condition over the most recent
decade. The 2013 French HIV Treatment Guidelines first called
for addressing the health of PLWH as understood by the World
Health Organization, meaning as a “state of complete physical,
mental and social well-being and not merely the absence of
disease or infirmity” [6]. The concept of HRQoL comes from
this definition of health and has become especially relevant to
those living with a chronic or recurrent illness.
HRQoL is a common patient-reported outcome (PRO). PROs
may be used at the population level for research and to improve
health care quality and at the individual patient level to support
clinical decision-making and ensure the efficient use of
resources. However, despite these potential benefits to both
clinicians and patients, PROs have yet to be routinely collected
or systematically used in routine care by clinicians [7]. This is
due to logistical, methodological, and attitudinal barriers [7].
Some of the first studies on the use of PROs in clinical practice
have yielded mixed results. There is strong evidence that having
patients complete a self-assessment before a medical visit can
facilitate communication about HRQoL [8-13]. Yet, the body
of evidence on whether this type of exercise alters patient
management, affects outcomes, or improves HRQoL or
satisfaction is less well understood [14]. Greenhalgh et al have
pointed to the lack of theory-driven approaches used to evaluate
the use of PRO measures in routine clinical practice and propose
that the mechanisms by which the proposed intervention is
hypothesized to affect patient outcomes be clearly delineated
[15]. Others like Basch et al have argued that the proliferation
of robust survey methods coupled with computerized
technologies has provided a potentially viable means of
collecting this information and ideally integrating it into
electronic medical records (EMR) [16]. Computerized and
touch-screen technology can substantially facilitate data
collection compared with paper forms, eliminating data-entry
and scoring time, and therefore decrease staff burden. Yet, often
EMRs and clinical research database systems have been
designed to allow for data entry from study staff, making the
collection of PROs challenging in some care or research settings
[17].
In the context of HIV cohort research, The University of
Washington HIV Cohort was among the first to experiment
with the routine computerized collection of patient-based
measures. Crane et al described efforts to institute the routine
collection of electronic PROs (ePROs) in HIV care, concluding
that it was both promising for research and clinical care [18].
Whereas Kozak et al highlighted some of the challenges of
capturing high-quality data in routine care and the limitations
of data recorded in patients’ paper medical or EMR [19]. They
note that the demands of clinical care and patients’ willingness
to disclose sensitive information may compromise the
comprehensiveness and the quality of data captured via EMRs.
In their 2012 study, conducted at the University of Alabama at
Birmingham 1917 HIV/AIDS clinic, they compared
self-reported and EMR data and looked at the association
between substance abuse, depression, and poor ART adherence
in PLWH. Not only did authors document significant differences
in the prevalence of self-reported vs EMR-documented
substance use and depression, but they found that the
self-reported rather than EMR-documented measures were better
correlated with poorer ART adherence [19]. This research
suggests that ePRO are an alternative and potentially more
reliable means of data capture for sensitive domains such as
substance use. Furthermore, ePROs may help clinicians identify
problems at the time of care, as demonstrated by Lawrence et
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al [20]. As part of the same initiative at the 1917 HIV/AIDS
Clinic, ePROs were used to detect suicidal ideation and trigger
an automated page to predetermined clinic personnel who
completed more detailed self-harm assessments [20].
Objectives
This paper outlines the formative research protocol being
undertaken to develop a Web-based system to collect ePROs
linked to the existing data capture infrastructure for those in
HIV care in southwestern France. The first aim of the ePRO
system is to expand and improve the data collection for the
ANRS CO3 Aquitaine Cohort of PLWH being followed up in
the 13 public hospitals in the region. The second aim is to make
this information available to clinicians in a convenient format
together with patients’ locally developed, HIV-specific EMR.
We describe the sequential process planned to ensure that the
proposed ePRO system is ready for formal pilot testing, referred
to herein as phases 1a and 1b. We also describe the planned
pilot testing designed to evaluate the acceptability and use of
the ePRO system from the perspective of patients (phase 2).
We have outlined the hypothesized changes induced by the
inclusion of these data in a locally developed HIV-specific
EMR, which is currently being developed.
Methods
Study Designs
The ANRS CO3 Aquitaine cohort is an open, prospective
hospital-based cohort. The proposed research was conceived as
an ancillary study to the cohort. This protocol reports on the
sequential study design from the prototyping (phase 1a) and
usability testing (phase 1b) to piloting (phase 2). Phases 1a and
1b rely on mostly qualitative methods. Perspectives of the
patient will be assessed and barriers to and facilitators of
implementation identified through usability testing. The second
phase of the research will initially be based on a cross-sectional
study design with the ultimate aim of collecting these data
longitudinally (at least once a year) and systematically via the
revised ePRO system.
Platform Design
Clinical and laboratory data from medical records have been
collected systematically as part of routine care by a team of
clinical research associates/technicians from 13 clinics/hospitals
throughout the Aquitaine region since the 1980s and via a locally
developed information technology (IT) solution, ARPEGE,
since 2013. ARPEGE is a secure Web-based data capture and
visualization system developed with Microsoft ASP.NET
(WebForm). Data are stored within a Microsoft SQL Server
2014-based data management system. A responsive Web-based
platform has been designed for patient follow-up within the
existing infrastructure of the ANRS CO3 Aquitaine Cohort.
This IT solution was originally developed to meet the data
collection requirements of the ANRS CO3 Aquitaine Cohort.
Unlike the hospital’s EMR, which did not allow for data to be
visualized nor used for research, ARPEGE provides HIV
physicians with patients’ medical histories. Its interoperability
with the surrounding health information system infrastructure
has evolved to allow laboratory data to be downloaded from
the Bordeaux University Hospital’s laboratory medicine
information system, which includes results of all tests performed
as part of hospital-based care. The proposed QuAliV ePRO
system expands upon this IT solution by developing a flexible
interface for the Web-based collection of ePROs both in a
hospital setting and beyond (in the patient’s home) with a special
focus on the presentation of individual patient’s results. The
inclusion of administrative data from the Program for
Medicalizing Information Systems and clinical data from the
hospital’s EMR is planned but has not yet been completed.
Initial Website Specifications
The primary feature of the ePRO system is the survey feature
due to the platform being nested within a longstanding
hospital-based cohort study. The first feature is to facilitate data
collection on HRQoL and its main determinants via validated
electronic questionnaires. The content of the patient interface
is based on current treatment guidelines for people being treated
for HIV and associated comorbidities [6]. French guidelines
recommend an annual checkup, during which a number of issues
should be addressed by the HIV physician according to the
patients’ age and sex. According to the taxonomy of applications
of PROs in clinical practice laid out by Greenhalgh, the proposed
system aims to optimize this checkup by having the patient
complete a standardized self-reported questionnaire before the
visit [10]. The proposed ePRO system relies on a selection of
validated questionnaires that were mostly already available in
French. The questionnaires have already been evaluated
individually according to their psychometric properties,
administration method, and length. The following areas are
covered by the ePRO system, broken up into thematic modules
covering: socioeconomic status and individual social and
material deprivation (Evaluation de la Précarité et des Inégalités
de santé dans les Centres d’Examens de Santé [EPICES]) [21],
multidimensional quality of life (WHOQOL-HIV BREF) [22],
treatment burden (Treatment Burden Questionnaire) [23],
physical activity (The Short Version of the International Physical
Activity Questionnaire [IPAQ]), alcohol use and screening for
at-risk drinking behavior (Alcohol Use Disorders Identification
Test Consumption [AUDIT-C], Fast Alcohol Consumption
Evaluation [FACE]) [24], tobacco and nicotine use and
screening for tobacco dependency (Fagerström), cannabis
(Cannabis Abuse Screening Test [CAST]) and drug use, and
finally, depression (Patient Health Questionniare [PHQ-9]) [25].
The system also allows patients to report any other
treatment-related issues in a free-text field. Where applicable,
we have followed the recommendations put forth by the
International Society for Pharmacoeconomics and Outcomes
Research ePRO Task Force on adapting paper-based instruments
to ensure that data produced are equivalent or superior to those
generated from paper-based administration methods [26]. It
should be noted that the choice of questionnaires for the initial
prototype is intentionally more exhaustive than the anticipated
final version, as we do not know whether the questionnaires
selected will be adequate in terms of their psychometric
properties. This will be verified during the pilot phase.
We have planned additional IT security measures including the
encryption of email addresses using the Advanced Encryption
Standard encryption algorithm with a key length of 256 bits.
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Advanced Encryption Standard encryption technology is
currently one of the most secure. Passwords will be encrypted
by the BCrypt algorithm, which is recognized as being at the
cutting edge of hash chain technology. Furthermore, passwords
created by the user must contain at least 8 alphanumeric
characters including at least 2 special characters, a capital letter,
and a number that must be changed every year. The unique
study-specific identification number will contain 8 randomly
defined alphanumeric characters.
Preimplementation (Phases 1A and 1B)
The IT solution, ARPEGE, has been made available in
hospital-based HIV care centers since 2013. Its use is facilitated
by research assistant technicians. To inform the implementation
strategy, taking into account the facilitators and barriers faced
by users, a preimplementation assessment identifying those
factors crucial to implementation success or failure will be
conducted before determining the final implementation
procedure.
Phase 1A: Prototyping (Eliciting Feedback on Initial
Specifications)
On the basis of the above specifications, a preliminary version
of the interface will be constructed and presented to patients to
elicit their feedback. The aim of the preliminary qualitative
interviews is not to rigorously evaluate the website’s
performance but to obtain information that could be used to
develop the interface and prepare it for formal pilot testing.
Using a semistructured interview guide, we will interview a
convenience sample of 10 HIV patients of varying ages,
transmission groups, and genders. During the interview, the
interviewer will present a mock-up of the Web-based patient
interface and describe its proposed functions to each participant.
Phase 1B: Usability Testing
Usability measures to what extent a person can use a system
for its goal effectively, efficiently, and satisfactorily [27].
Usability testing will be conducted on the prototype of the ePRO
system according to guidelines from the website Usability.gov
[28]. A convenience sample of 10 patients will be recruited and
interviewed in an outpatient hospital setting. This sample is
considered adequate to evaluate whether the website is ready
for planned, more rigorous, pilot testing [29]. Eligible patients,
identified by clinical staff, will be approached for the study
before their scheduled visit. During usability testing, patients
will access the website and test its features, including the site
login, survey completion, and review of results. Patients will
“think aloud” as they complete the login process and survey
and complete a semistructured interview about the ease of use
and completion, presence of mistakes or problems, user
satisfaction, likes/dislikes, and their willingness to use it
regularly before visits. Efficiency (eg, time it takes to complete
tasks) will also be monitored. Finally, participants will also be
asked to complete the System Usability Scale (SUS), a validated
10-item scale with Likert-scaled responses ranging from
“strongly agree” to “strongly disagree” and a summary score
[28].
The findings from this first phase (1a and 1b) will inform the
second phase of the study, which will extend the implementation
of the proposed patient interface in a limited number of hospitals
and aims to evaluate its acceptability and use.
Phase 2: Pilot Testing
Proposed Setting
The study will be carried out in the ANRS CO3 Aquitaine
Cohort, an open, prospective, hospital-based cohort of PLWH
followed-up in 13 clinics in southwestern France. The pilot
testing will take place in 3 of them, selected to reflect variations
in resources (human and material) or geographic setting (rural
vs urban clinics). We aim to assess the acceptability of the
proposed system in different clinical contexts to eventually offer
center-specific adjustments to the proposed implementation
procedures.
Inclusion and Exclusion Criteria (Phase 2)
As this study will be nested within a longstanding existing
hospital-based cohort of PLWH, those invited to participate in
this study must meet the cohort’s eligibility criteria: aged 18
years or older, confirmed HIV-1 diagnosis, and having signed
a consent form. Access to a personal email account and the
internet via either a computer or smartphone in a private setting
will be verified by the clinician before the participant is invited
to engage with ePRO system. Patients who express an interest
in completing a self-reported questionnaire but lack either a
personal computer or smartphone and/or reliable internet access
will be provided with a paper version questionnaire or,
depending on the study center, invited to use a study-specific
electronic tablet (Samsung Galaxy Tab S2).
Patient Selection and Recruitment
Patient selection and recruitment will be done in tandem with
planned administrative changes to the cohort and will take place
during routine care. The standard operating procedures detailing
the new procedures for including participants in this component
of the cohort have been developed during successive team
meetings. Before each visit, on-site research assistants will
provide clinicians with a study-specific randomly generated
patient identifier. Clinicians will invite patients to participate
in the ANRS CO3 Aquitaine cohort’s new research initiative
at the time of the consultation. Figure 1 outlines the integration
of the QuAliV patient portal in the ANRS CO3 Aquitaine
Cohort.
Once the eligibility criteria have been verified, if the patient
wishes to participate in the study, he/she will be provided with
a patient-oriented brochure developed specifically for those
interested in engaging with the system. The study-specific
identifier required for participants to create their accounts will
then be noted on a detachable part of the patient-oriented
brochure for easy reference. This study-specific identifier is
required to create an account via ARPEGE. It allows for the
patient account and the self-reported data to be linked to the
existing clinical data capture and visualization system
(ARPEGE).
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Figure 1. Integration of the QuAliV patient portal in the ANRS CO3 Aquitaine Cohort.
As the patients could be accessing the website from their phones
or from their home computers, the section of the brochure for
noting the study-specific identifier will be detachable, allowing
the study participant to leave the brochure at the hospital for
the sake of confidentiality (Multimedia Appendix 1). To monitor
study enrollment and ascertain whether the proposed system is
acceptable to users, enrollment will be tracked by the centers.
Eligible participants will be directed to the study website where
they will be provided with additional details about the research
initiative and its aims. The website will provide additional
information to “recruited” patients, encouraging them to take
a more active role in his or her HIV care and well-being. The
patient will be redirected to the account creation page, powered
by ARPEGE. To ensure that the participant created his/her
account successfully, he/she will be asked to enter his/her email
twice together with the unique patient identifier. The patient
will then be asked to confirm his/her email address before he/she
can access the patient portal. Metadata will be monitored to
identify any bottlenecks during the pilot phase.
Study Population
The cohort’s “active follow-up” is defined as patients who have
been seen over the course of the previous year either at a
hospital-based consultation or been hospitalized. In 2016,
approximately 4480 patients were actively being followed-up
in the cohort. The average length of follow up is 12 years post
HIV diagnosis. In total, 27.95% (1252/4480) of the cohort is
female and mean age is 51 years (SD 11 years). The majority
of the cohort contracted HIV through sex (41.93% (1881/4486)
are men who have sex with men and 37.09% (1664/4486) are
heterosexuals) and 12.75% (572/4486) through injection drug
use. Moreover, 20.60% (923/4480) of those in active follow-up
have been diagnosed with AIDS, 26.70% (1010/3745) are
overweight, and 8.62% (323/3745) are obese. In addition,
43.71% (1831/4189) report being current smokers.
Statistical Analysis
Feedback on initial specification from patients will be evaluated
qualitatively during phase 1a. During phase 1b, in addition to
qualitative feedback provided using the “think aloud” approach
and semistructured interview, we will define success in usability
a priori as SUS score reaching a ceiling effect: with a minimum
score of 70 as the generally accepted cutoff usability rating for
“good” [27]. For each measure, we will also calculate the
percentage of completed items by the total number of items for
each PROs module.
We will monitor eligibility, QuAliV numbers issued, accounts
created, and initial questionnaires completed within 1 month of
the visit. The following process indicators will be used to assess
acceptability:
• The proportion of people who refused to participate in the
study
• the proportion of those who received information but failed
to create an account
• The proportion of those who created an account but failed
to complete the questionnaires
To assess use, the main outcomes of interest of the phase 2 study
are the overall participation rate (proportion of those who created
an account and completed the assessment) implemented as a
pilot and the participation rates based on readily available
personal, demographic, and treatment-related factors.
Differences based on age, sociodemographic characteristics
(including rural vs urban), and clinic and transmission groups
will be evaluated using the chi-square test. Determinants of use
will be evaluated using logistic regression methods.
As all the questionnaires will be used in an electronic form, the
psychometric properties of the instruments included in the
patient portal will also be verified. We will be especially
attentive to the presence of floor and ceiling effects (60% of
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responses in extreme categories). We will also monitor the time
it takes to complete the questionnaire as a further indicator of
feasibility. The dimension of HRQoL measured by the
instruments will be assessed using confirmatory factor analysis.
Finally, we will use the pilot phase to verify the distribution of
the main outcome of interest (HRQoL) of our epidemiological
study, seeking to measure both the prevalence and the
determinants of poorer HRQoL in PLWH in the current HIV
treatment era. We will use this initial sample to calculate the
required sample size and plan for the scale up of the platform
in all of the participating hospitals/clinics in the region.
Ethical and Legal Aspects
The implementation of this study called for an amended version
of the cohort protocol to be submitted to an ethics committee.
This amendment entailed a detailed description of the content
of the questionnaires included in the ePRO system, the content
of patient-oriented brochure and the external patient-oriented
website. Approval was granted in August 2017.
As the implementation of this system requires patients to use
their email addresses to create their personal accounts, an
amendment to the regulatory authorizations previously granted
to the cohort by The French National Commission on
Informatics and Liberty, an independent administrative
regulatory body charged with ensuring that data privacy laws
are applied to the collection, storage, and use of personal data,
was requested in late 2017 and approval was granted on March
12, 2018.
Results
Seed funding was granted by France REcherche Nord&Sud
Sida-hiv Hépatites (ANRS) in 2017 via the CSS-5 call in
January, 2017 and additional staff recruited in June 2017 to
develop the ePRO system’s infrastructure. DB was awarded a
36-month “young researcher” grant from Sidaction to design
and conduct this study within the ANRS CO3 Aquitaine cohort
as part of her doctoral research.
The development of the prototype of QuAliV ePRO system and
the first 2 phases of the study will be conducted between
December 2017 and May 2018. The results from phase 1 will
ultimately inform the implementation of the pilot project. Efforts
to integrate data generated from the ePROs system into a
HIV-specific EMR will begin in April 2018 as part of the next
phase of APREGE’s development. Enrollment of participants
is planned in June 2018.
Discussion
Although France boasts a robust public health and
epidemiological surveillance system, its cohorts relied, until
recently, on paper-based data collection methods. The Aquitaine
cohort, launched in 1987, transitioned to an electronic Case
Report Form supported by center-based clinical research
technicians in 2013. The relatively recent transition to an
electronic data capture and visualization system has made the
collection of ePROs in hospital-based cohort studies of PLWH
conceivable and timely in light of the current HIV care paradigm
in France. The introduction of the proposed ePRO system and
updated physician HIV-specific EMR, presenting a summary
of patients’ clinical, laboratory, and self-reported records, will
imply changing both patient behavior and daily clinical practice.
In line with recommendations put forth by Greenhalgh and
colleagues, we have diagrammed the hypothesized mechanisms
by which this patient ePRO system is designed to promote
improved patient-physician communication (Figure 2, adapted
from Greenhalgh et al) [15]. The results of the self-reported
questionnaires will be summarized for clinicians in a convenient
format developed in collaboration with end users. We
hypothesize that providing this information can improve
communication and, thus, lead to better quality of care (both
patient satisfaction and health outcomes). Presenting this
information will also allow HIV physicians to monitor the
patient’s response to treatment over time (ART and treatment
for associated comorbidities) and/or detect issues that may have
previously gone unnoticed (eg, a change in employment status,
living conditions, addictions, a lack of social support,
depression, and/or a decline in HRQoL). We hypothesize that
physicians will also be better equipped to discuss
health-promoting behaviors such as exercise or smoking
cessation, adjust treatment regimens, or refer patients to a
specialist or allied health professionals (eg, therapist, dietician,
social worker).
As the underlying IT solution, ARPEGE, was developed in
house, should the phases 1a and 1b and phase 2 studies,
presented here, yield promising results, the panel of services
provided via the proposed ePRO system could ultimately be
expanded. For example, continuous patient education/coaching
for better self-management, similar to interventions that have
been implemented for other chronic conditions (diabetes, heart
disease, etc), could be offered, as could decentralized models
of care and/or facilitated communication with one’s general
practitioner. The adoption of these different services could
ultimately be the aim of future experimental research in this
patient population aging with HIV. Alternatively, the proposed
system, designed for outpatient hospital-based HIV care, could
be adapted for use in other chronic diseases and/or other care
settings.
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Figure 2. Hypothesized change to clinical decision making resulting from use of the ePRO system, adapted from Greenhalgh et al.
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